ZNF484
gene geneOn this page
Also known as BA526D8.4FLJ33884
Summary
ZNF484 (zinc finger protein 484, HGNC:23385) is a protein-coding gene on chromosome 9q22.31, encoding Zinc finger protein 484 (Q5JVG2). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 83744 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 118 total
- MANE Select transcript:
NM_031486
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23385 |
| Approved symbol | ZNF484 |
| Name | zinc finger protein 484 |
| Location | 9q22.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | BA526D8.4, FLJ33884 |
| Ensembl gene | ENSG00000127081 |
| Ensembl biotype | protein_coding |
| Entrez | 83744 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000332591, ENST00000375495, ENST00000395505, ENST00000395506, ENST00000718324, ENST00000855340, ENST00000855341, ENST00000855342
RefSeq mRNA: 7 — MANE Select: NM_031486
NM_001007101, NM_001261458, NM_001261459, NM_001261460, NM_001354536, NM_001354537, NM_031486
CCDS: CCDS35066, CCDS35067, CCDS59136
Canonical transcript exons
ENST00000375495 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000869903 | 92855811 | 92855903 |
| ENSE00002258811 | 92875015 | 92875059 |
| ENSE00003685220 | 92856192 | 92856318 |
| ENSE00004034781 | 92877890 | 92878038 |
| ENSE00004034782 | 92844182 | 92848551 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 87.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.8996 / max 215.3042, expressed in 1519 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 101453 | 5.8996 | 1519 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus callosum | UBERON:0002336 | 87.67 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.04 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.50 | gold quality |
| adrenal tissue | UBERON:0018303 | 79.51 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.97 | gold quality |
| cortical plate | UBERON:0005343 | 78.47 | gold quality |
| ventricular zone | UBERON:0003053 | 77.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.05 | gold quality |
| colonic epithelium | UBERON:0000397 | 75.54 | gold quality |
| islet of Langerhans | UBERON:0000006 | 74.78 | gold quality |
| bone marrow cell | CL:0002092 | 73.56 | silver quality |
| bone marrow | UBERON:0002371 | 73.48 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.33 | gold quality |
| tonsil | UBERON:0002372 | 73.10 | gold quality |
| endometrium | UBERON:0001295 | 72.43 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 72.04 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.71 | gold quality |
| cerebellum | UBERON:0002037 | 71.70 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.56 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.26 | gold quality |
| sural nerve | UBERON:0015488 | 71.02 | gold quality |
| leukocyte | CL:0000738 | 70.78 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 70.77 | gold quality |
| monocyte | CL:0000576 | 70.59 | gold quality |
| prefrontal cortex | UBERON:0000451 | 70.30 | gold quality |
| primary visual cortex | UBERON:0002436 | 70.20 | gold quality |
| lymph node | UBERON:0000029 | 69.63 | gold quality |
| urinary bladder | UBERON:0001255 | 69.32 | gold quality |
| frontal cortex | UBERON:0001870 | 68.91 | gold quality |
| placenta | UBERON:0001987 | 68.90 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.45 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
68 targeting ZNF484, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 484 — Q5JVG2 (reviewed: Q5JVG2)
All UniProt accessions (1): Q5JVG2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5JVG2-1 | 1 | yes |
| Q5JVG2-2 | 2 | |
| Q5JVG2-3 | 3 |
RefSeq proteins (7): NP_001007102, NP_001248387, NP_001248388, NP_001248389, NP_001341465, NP_001341466, NP_113674* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (77 total): strand 29, zinc finger region 19, helix 17, turn 5, cross-link 2, splice variant 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
13 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2EMF | SOLUTION NMR | |
| 2EMG | SOLUTION NMR | |
| 2EMH | SOLUTION NMR | |
| 2EMI | SOLUTION NMR | |
| 2EOV | SOLUTION NMR | |
| 2EP1 | SOLUTION NMR | |
| 2EP2 | SOLUTION NMR | |
| 2EP3 | SOLUTION NMR | |
| 2EQW | SOLUTION NMR | |
| 2YTJ | SOLUTION NMR | |
| 2YTO | SOLUTION NMR | |
| 2YTP | SOLUTION NMR | |
| 2YTS | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JVG2-F1 | 60.52 | 0.11 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 156, 816
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 74 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, chr9q22, CUI_TCF21_TARGETS_2_DN, IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, LEE_BMP2_TARGETS_DN, PEDRIOLI_MIR31_TARGETS_UP, RAO_BOUND_BY_SALL4_ISOFORM_B, ARID5B_TARGET_GENES, ARNT2_TARGET_GENES, ATF5_TARGET_GENES, BARX1_TARGET_GENES, CIITA_TARGET_GENES, DIDO1_TARGET_GENES, E2F2_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
312 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF484 | SMIM9 | A6NGZ8 | 638 |
| ZNF484 | SMIM19 | Q96E16 | 514 |
| ZNF484 | MGAT4B | Q9UQ53 | 343 |
| ZNF484 | CSTF2T | Q9H0L4 | 338 |
| ZNF484 | INO80D | Q53TQ3 | 325 |
| ZNF484 | RNF121 | Q9H920 | 323 |
| ZNF484 | PRRC2C | Q9Y520 | 316 |
| ZNF484 | GTF2IRD1 | Q9UHL9 | 308 |
| ZNF484 | HMBOX1 | Q6NT76 | 304 |
| ZNF484 | AAMP | Q13685 | 301 |
| ZNF484 | FOXN2 | P32314 | 272 |
| ZNF484 | STK36 | Q9NRP7 | 265 |
| ZNF484 | UQCRQ | O14949 | 263 |
| ZNF484 | COX7A2 | P14406 | 254 |
| ZNF484 | PCGF5 | Q86SE9 | 247 |
| ZNF484 | ENSA | O43768 | 247 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF484 | KRT8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNF484 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF484 | ZNF195 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF484 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): ZNF484 (Affinity Capture-RNA), ZNF484 (Affinity Capture-RNA), ZNF484 (Proximity Label-MS), TRIM33 (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), ZNF195 (Affinity Capture-MS), SMARCAD1 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), TRIM37 (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), ZYG11A (Affinity Capture-MS), ZNF484 (Protein-peptide)
ESM2 similar proteins: A2VDP4, A6NHJ4, O94892, P0CJ79, P17014, P17021, P17025, P17032, P17035, P18733, P51508, P51814, Q06730, Q06732, Q09FC8, Q0VGE8, Q14586, Q32M78, Q3MIS6, Q5JVG2, Q5R4K8, Q5R9S5, Q5RBQ3, Q5RCJ2, Q5RER9, Q5TYW1, Q5VIY5, Q6P560, Q6PDB4, Q6ZMW2, Q6ZN06, Q6ZNA1, Q76KX8, Q7L2R6, Q86Y25, Q8N184, Q8N823, Q8N883, Q8N8J6, Q8NEP9
Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
118 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 102 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
997 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:92848547:CCCAT:C | acceptor_gain | 1.0000 |
| 9:92848548:CCAT:C | acceptor_gain | 1.0000 |
| 9:92848548:CCATC:C | acceptor_gain | 1.0000 |
| 9:92848549:CAT:C | acceptor_gain | 1.0000 |
| 9:92848549:CATC:C | acceptor_gain | 1.0000 |
| 9:92848551:TCTAA:T | acceptor_loss | 1.0000 |
| 9:92848552:C:CC | acceptor_gain | 1.0000 |
| 9:92854094:C:CT | acceptor_gain | 1.0000 |
| 9:92854095:A:T | acceptor_gain | 1.0000 |
| 9:92856190:A:AC | donor_gain | 1.0000 |
| 9:92856191:C:CC | donor_gain | 1.0000 |
| 9:92856191:CCCA:C | donor_gain | 1.0000 |
| 9:92856316:TTC:T | acceptor_gain | 1.0000 |
| 9:92856317:TC:T | acceptor_gain | 1.0000 |
| 9:92856318:CC:C | acceptor_gain | 1.0000 |
| 9:92856319:C:CA | acceptor_loss | 1.0000 |
| 9:92856319:C:CC | acceptor_gain | 1.0000 |
| 9:92856320:T:A | acceptor_loss | 1.0000 |
| 9:92848550:AT:A | acceptor_gain | 0.9900 |
| 9:92854089:T:TC | acceptor_gain | 0.9900 |
| 9:92854094:C:T | acceptor_gain | 0.9900 |
| 9:92855900:CATC:C | acceptor_gain | 0.9900 |
| 9:92855901:ATCCT:A | acceptor_loss | 0.9900 |
| 9:92855902:TC:T | acceptor_gain | 0.9900 |
| 9:92855903:CC:C | acceptor_gain | 0.9900 |
| 9:92855903:CCTGT:C | acceptor_loss | 0.9900 |
| 9:92855904:C:CC | acceptor_gain | 0.9900 |
| 9:92855905:T:A | acceptor_loss | 0.9900 |
| 9:92855911:C:CT | acceptor_gain | 0.9900 |
| 9:92856186:GCTT:G | donor_loss | 0.9900 |
AlphaMissense
5727 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:92846600:G:C | F729L | 0.999 |
| 9:92846600:G:T | F729L | 0.999 |
| 9:92846602:A:G | F729L | 0.999 |
| 9:92846684:A:C | F701L | 0.999 |
| 9:92846684:A:T | F701L | 0.999 |
| 9:92846686:A:G | F701L | 0.999 |
| 9:92846768:G:C | F673L | 0.999 |
| 9:92846768:G:T | F673L | 0.999 |
| 9:92846770:A:G | F673L | 0.999 |
| 9:92846852:A:C | F645L | 0.999 |
| 9:92846852:A:T | F645L | 0.999 |
| 9:92846854:A:G | F645L | 0.999 |
| 9:92847255:A:G | L511P | 0.999 |
| 9:92846432:G:C | F785L | 0.998 |
| 9:92846432:G:T | F785L | 0.998 |
| 9:92846434:A:G | F785L | 0.998 |
| 9:92846516:G:C | F757L | 0.998 |
| 9:92846516:G:T | F757L | 0.998 |
| 9:92846518:A:G | F757L | 0.998 |
| 9:92846751:A:G | L679P | 0.998 |
| 9:92846825:G:C | H654Q | 0.998 |
| 9:92846825:G:T | H654Q | 0.998 |
| 9:92846936:G:C | F617L | 0.998 |
| 9:92846936:G:T | F617L | 0.998 |
| 9:92846938:A:G | F617L | 0.998 |
| 9:92847104:G:C | F561L | 0.998 |
| 9:92847104:G:T | F561L | 0.998 |
| 9:92847106:A:G | F561L | 0.998 |
| 9:92847272:A:C | F505L | 0.998 |
| 9:92847272:A:T | F505L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000092652 (9:92849798 CTCTT>C), RS1000347631 (9:92877720 C>T), RS1000446508 (9:92850095 C>T), RS1000448579 (9:92871564 A>T), RS1000643068 (9:92878977 T>C), RS1000739784 (9:92871826 C>T), RS1000756193 (9:92849859 T>C), RS1000907012 (9:92857345 G>T), RS1001078312 (9:92878752 C>T), RS1001088301 (9:92871858 G>A,T), RS1001371921 (9:92851469 G>A), RS1001633797 (9:92870887 G>A), RS1001698708 (9:92851754 T>C), RS1001705699 (9:92874098 C>A,T), RS1001777840 (9:92873824 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001524_22 | Visceral adipose tissue/subcutaneous adipose tissue ratio | 2.000000e-06 |
| GCST006979_360 | Heel bone mineral density | 2.000000e-23 |
| GCST010725_16 | Malaria | 9.000000e-06 |
| GCST010725_28 | Malaria | 6.000000e-06 |
| GCST010725_95 | Malaria | 6.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004767 | visceral:subcutaneous adipose tissue ratio |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases abundance, increases expression | 2 |
| Particulate Matter | decreases reaction, increases expression, increases abundance | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| cupric oxide | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | increases expression, decreases reaction | 1 |
| jinfukang | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Vehicle Emissions | decreases reaction, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Urethane | increases expression | 1 |
| Vanadates | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.